GUANGDONG TAIANTANG PHARMACEUTICAL CO., LTD.

Guangdong Taiantang Pharmaceutical Co., Ltd.

002433

CNE100000Q92

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 26/06/2024 am IST			5-day change	1st Jan Change
0.3 ^CNY	+11.11%		+20.00%	-87.34%

13/06	Guangdong Taiantang Pharmaceutical Co., Ltd.(SZSE:002433) dropped from Shenzhen Stock Exchange Composite Index	CI
13/06	Guangdong Taiantang Pharmaceutical Co., Ltd.(SZSE:002433) dropped from Shenzhen Stock Exchange A Share Index	CI

Guangdong Taiantang Pharmaceutical Co., Ltd.(SZSE:002433) dropped from Shenzhen Stock Exchange Composite Index

June 13, 2024

Guangdong Taiantang Pharmaceutical Co., Ltd. has been dropped from Shenzhen SE Composite index.

Latest news about Guangdong Taiantang Pharmaceutical Co., Ltd.

Guangdong Taiantang Pharmaceutical Co., Ltd.(SZSE:002433) dropped from Shenzhen Stock Exchange Composite Index	13/06	CI
Guangdong Taiantang Pharmaceutical Co., Ltd.(SZSE:002433) dropped from Shenzhen Stock Exchange A Share Index	13/06	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Approves Board Elections	21/23/21	CI
Shantou Real Estate Hexin Co., Ltd. acquired Shantou Tai'an Investment Development Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for CNY 240 million.	13/22/13	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	15/22/15	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Auditor Raises 'Going Concern' Doubt	15/22/15	CI
Shantou Real Estate Hexin Co., Ltd. agreed to acquire Shantou Tai'an Investment Development Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for CNY 240 million.	14/21/14	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	29/21/29	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	27/21/27	CI
Chengdu Yiyun Technology Co., Ltd. completed the acquisition of a 47.35% stake in Guangdong Kangaiduo Digital Health Technology Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd..	25/21/25	CI
Guangdong Hongding Real Estate Investment Development Group Co., Ltd. agreed to acquire 25% stake in Guangzhou Jinpibao Property Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for approximately CNY 220 million.	22/21/22	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Not to Pay Dividend for the Year 2020	11/21/11	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/21/28	CI
Guangdong Taiantang Plans to Sell Stake in Digital Health Technology Firm	22/21/22	CI
Chengdu Yiyun Technology Co., Ltd. agreed to acquire a 47.35% stake in Guangdong Kangaiduo Digital Health Technology Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for approximately CNY 750 million.	22/21/22	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	09/21/09	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	27/20/27	CI

Chart Guangdong Taiantang Pharmaceutical Co., Ltd.

Duration

Period

Chart Guangdong Taiantang Pharmaceutical Co., Ltd.

More charts

Guangdong Taiantang Pharmaceutical Co Ltd is a company mainly engaged in the manufacturing of Chinese patent medicines and the primary processing of Chinese medicinal materials. The Company operates five segments. Chinese Patent Medicines Manufacturing Business segment is mainly responsible for the production and wholesale of Pibao cream, Qilin pill, Xinbao pill, Xinxin pill, Tongqiao Yixin pill, etc. Primary Processing Business segment of the traditional Chinese medicine materials is mainly responsible for planting, primary processing and sales of the ginseng and traditional Chinese medicine materials. Drug Wholesale and Retail Business segment is mainly responsible for the wholesale and retail of drugs and medical devices. Health Industry Development and Products Sales segment is mainly responsible for the development and sales of health concept real estate products. Medical Services segment is mainly responsible for the in-depth development of medical and elderly care services.

Sector

Pharmaceuticals

Calendar

23/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
GUANGDONG TAIANTANG PHARMACEUTICAL CO., LTD.	-87.34%	28.51M
DONG-E-E-JIAO CO.,LTD.	+29.99%	5.69B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.99%	3.53B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.59%	3.06B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.15%	2.62B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-9.23%	2.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+42.55%	1.86B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+44.37%	1.43B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-11.29%	1.41B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+42.86%	1.4B